Liver-expressed ASK1 as potential therapeutic target for obesity and associated diseases
Sep. 29, 2022
Researchers from the University of Zurich presented data from a study that aimed to investigate the impact of liver-specific apoptosis signal regulating kinase 1 (ASK1) overexpression on the development of high-fat diet (HFD)-induced obesity and impaired glucose metabolism.